TET2 in normal and malignant hematopoiesis Journal Article


Authors: Bowman, R. L.; Levine, R. L.
Article Title: TET2 in normal and malignant hematopoiesis
Abstract: The ten-eleven translocation (TET) family of enzymes were originally cloned from the translocation breakpoint of t(10;11) in infant acute myeloid leukemia (AML) with subsequent genomic analyses revealing somatic mutations and suppressed expression of TET family members across a range of malignancies, particularly enriched in hematological neoplasms. The TET family of enzymes is responsible for the hydroxylation of 5-methylcytosines (5-mC) to 5-hydroxymethylcytosine (5-hmC), followed by active and passive mechanisms leading to DNA demethylation. Given the complexity and importance of DNA methylation events in cellular proliferation and differentiation, it comes as no surprise that the TET family of enzymes is intricately regulated by both small molecules and regulatory cooperating proteins. Here, we review the structure and function of TET2, its interactions with cooperating mutations and small molecules, and its role in aberrant hematopoiesis. Copyright © 2017 Cold Spring Harbor Laboratory Press; all rights reserved.
Keywords: dna binding protein; oncoprotein; tet2 protein, human; genetics; mutation; dna-binding proteins; proto-oncogene proteins; metabolism; cell differentiation; dna methylation; physiology; gene expression regulation; gene expression regulation, neoplastic; hematologic neoplasms; epigenesis, genetic; hematopoiesis; genetic epigenesis; oxidation reduction reaction; oxidation-reduction; hematologic disease; 5 methylcytosine; 5-methylcytosine; humans; human
Journal Title: Cold Spring Harbor Perspectives in Medicine
Volume: 7
Issue: 8
ISSN: 2157-1422
Publisher: Cold Spring Harbor Laboratory Press  
Date Published: 2017-08-01
Start Page: a026518
Language: English
DOI: 10.1101/cshperspect.a026518
PUBMED: 28242787
PROVIDER: scopus
PMCID: PMC5538403
DOI/URL:
Notes: Review -- Export Date: 1 June 2018 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Ross Levine
    784 Levine
  2. Robert L Bowman
    52 Bowman